Bone-Specific Drug Delivery Systems
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 42 (15) , 1319-1330
- https://doi.org/10.2165/00003088-200342150-00002
Abstract
Despite several decades of progress, bone-specific delivery is still limited by the unique anatomical features of bone, which mainly consists of inorganic hydroxyapatite. A practical approach to this...Keywords
This publication has 59 references indexed in Scilit:
- Apatite cement containing cis-diamminedichloroplatinum implanted in rabbit femur for sustained release of the anticancer drug and bone formationJournal of Orthopaedic Science, 2001
- In vivo–in vitro study of biodegradable and osteointegrable gentamicin bone implantsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- Cancer therapy using bone-seeking isotopesPhysics in Medicine & Biology, 1996
- Synthesis of gem-bisphosphonic methotrexate conjugates and their biological response towards Walker's osteosarcomaEuropean Journal of Medicinal Chemistry, 1993
- The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice. The effects of vehicle and the route of administrationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- Therapeutic efficacy of two different cytostatic-linked phosphonates in combination with razoxane in the transplantable osteosarcoma of the ratClinical & Experimental Metastasis, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- TREATMENT OF PAGET'S DISEASE OF BONEClinical Endocrinology, 1990
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Diphosphonates: History and mechanisms of actionMetabolic Bone Disease and Related Research, 1981